Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.
Iambic has raised $100.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Iambic's investors include Sequoia Capital, NVIDIA, Alumni Ventures, OrbiMed, Nexus Venture Partners.
Iambic is headquartered in San Diego, United States.
Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.
Iambic is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Iambic — Funding & Investors." VCBacked, November 10, 2025, https://www.vcbacked.co/company/iambic. Accessed September 2, 2026.
VCBacked. (2025). Iambic — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/iambic
{{cite web |title=Iambic — Funding & Investors |url=https://www.vcbacked.co/company/iambic |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated